| 1 |
Malave B. Metabolic and hormonal dysfunction in asymptomatic patient using selective androgen receptor modulators: a case report. Bull Natl Res Cent 2023;47:11. [DOI: 10.1186/s42269-023-00989-z] [Reference Citation Analysis]
|
| 2 |
Xing H, Wang Y, Qu B, Wei Q, Li C, Pan C, Li H. The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity. Transl Oncol 2023;28:101619. [PMID: 36623392 DOI: 10.1016/j.tranon.2023.101619] [Reference Citation Analysis]
|
| 3 |
Ardila-Suárez OM, Oriz-Benjumea L, Arteta AA, Guevara-Casallas LG. Drug-induced liver injury: Relation between the R ratio and histopathology. Rev Gastroenterol Mex (Engl Ed) 2023;88:19-27. [PMID: 35523682 DOI: 10.1016/j.rgmxen.2022.03.006] [Reference Citation Analysis]
|
| 4 |
Teschke R. Treatment of Drug-Induced Liver Injury. Biomedicines 2022;11. [PMID: 36672522 DOI: 10.3390/biomedicines11010015] [Reference Citation Analysis]
|
| 5 |
Ma CD, Faust D, Bonkovsky HL. Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria. Mol Genet Metab Rep 2023;34:100946. [PMID: 36578356 DOI: 10.1016/j.ymgmr.2022.100946] [Reference Citation Analysis]
|
| 6 |
Trontzas IP, Kyriakoulis KG, Vathiotis IA, Syrigos A, Kounadis G, Siasiakou S, Poulakou G. Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence? Vaccines (Basel) 2022;10. [PMID: 36560483 DOI: 10.3390/vaccines10122073] [Reference Citation Analysis]
|
| 7 |
Koshy A, Mahadevan P, Mukkada RJ, Francis JV, Chettupuzha AP, Augustine P. Spectrum of drug-induced liver injury in a tertiary hospital in southern India. NMJI 2022;35:78-81. [DOI: 10.25259/nmji_112_19] [Reference Citation Analysis]
|
| 8 |
Monge-Urrea F, Montijo-Barrios E. Drug-induced Liver Injury in Pediatrics. J Pediatr Gastroenterol Nutr 2022;75:391-5. [PMID: 35727646 DOI: 10.1097/MPG.0000000000003535] [Reference Citation Analysis]
|
| 9 |
Naseralallah LM, Aboujabal BA, Geryo NM, Al Boinin A, Al Hattab F, Akbar R, Umer W, Abdul Jabbar L, Danjuma MI. The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome. PLoS ONE 2022;17:e0268705. [DOI: 10.1371/journal.pone.0268705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Plüß M, Tampe D, Schwörer H, Bremer SCB, Tampe B. Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM. Front Pharmacol 2022;13:966910. [DOI: 10.3389/fphar.2022.966910] [Reference Citation Analysis]
|
| 11 |
Cheng YL, Chang WK, Yen H, Peng YJ, Chang WC, Chang PY. Osimertinib-related liver injury with successful osimertinib rechallenge: A case report. Thorac Cancer 2022. [PMID: 35793806 DOI: 10.1111/1759-7714.14556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Lewis JH, Khaldoyanidi SK, Britten CD, Wei AH, Subklewe M. Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology. Am J Clin Oncol 2022. [PMID: 35848749 DOI: 10.1097/COC.0000000000000932] [Reference Citation Analysis]
|
| 13 |
Hasan Khudhair D, Al-gareeb AI, Al-kuraishy HM, El-kadem AH, Elekhnawy E, Negm WA, Saber S, Cavalu S, Tirla A, Alotaibi SS, Batiha GE. Combination of Vitamin C and Curcumin Safeguards Against Methotrexate-Induced Acute Liver Injury in Mice by Synergistic Antioxidant Effects. Front Med 2022;9:866343. [DOI: 10.3389/fmed.2022.866343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 14 |
Shi X, Lao D, Xu Q, Li X, Lv Q. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infect Dis 2022;22:368. [PMID: 35410140 DOI: 10.1186/s12879-022-07258-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Soares PF, Fernandes MTCF, Souza AS, Lopes CM, Dos Santos DAC, Oliveira DPR, Pereira MG, Prado NMBL, Gomes GSDS, Santos G Junior, Paraná R. Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review. Ann Hepatol 2021;25:100539. [PMID: 34555512 DOI: 10.1016/j.aohep.2021.100539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Rodríguez A, García-garcía I, Martínez de Soto L, Gómez López De Las Huertas A, Borobia AM, González-torbay A, Akatbach-bousaid I, González-muñoz M, Ramírez E. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study. Front Pharmacol 2022;13:819589. [DOI: 10.3389/fphar.2022.819589] [Reference Citation Analysis]
|
| 17 |
Scoazec JY. Drug-induced bile duct injury: new agents, new mechanisms. Curr Opin Gastroenterol 2022;38:83-8. [PMID: 34931623 DOI: 10.1097/MOG.0000000000000813] [Reference Citation Analysis]
|
| 18 |
Ardila-suárez O, Oriz-benjumea L, Arteta A, Guevara-casallas L. Daño hepático inducido por medicamentos: relación entre el índice R y la histopatología. Revista de Gastroenterología de México 2022. [DOI: 10.1016/j.rgmx.2021.03.008] [Reference Citation Analysis]
|
| 19 |
Studentova H, Volakova J, Spisarova M, Zemankova A, Aiglova K, Szotkowski T, Melichar B. Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02121-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Bessone F, Hernandez N, Tagle M, Arrese M, Parana R, Méndez-Sánchez N, Ridruejo E, Mendizabal M, Dagher L, Contreras F, Fassio E, Pessoa M, Brahm J, Silva M. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver. Ann Hepatol 2021;24:100321. [PMID: 33609753 DOI: 10.1016/j.aohep.2021.100321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 21 |
Nunes DRDCMA, Monteiro CSDJ, dos Santos JL. Herb-Induced Liver Injury—A Challenging Diagnosis. Healthcare 2022;10:278. [DOI: 10.3390/healthcare10020278] [Reference Citation Analysis]
|
| 22 |
Chbili C, Fathallah N, Laadhari C, Ouni B, Saguem S, Ben Fredj M, Abdelghani A, Ben Saad H, Ben Salem C. Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene 2022;809:146019. [PMID: 34656741 DOI: 10.1016/j.gene.2021.146019] [Reference Citation Analysis]
|
| 23 |
Teschke R, Danan G. Causality Assessment in Pharmacovigilance for Herbal Medicines. Pharmacovigilance for Herbal and Traditional Medicines 2022. [DOI: 10.1007/978-3-031-07275-8_10] [Reference Citation Analysis]
|
| 24 |
Khan Z, Karataş Y, Kıroğlu O. Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital. Front Pharmacol 2021;12:786182. [PMID: 34867419 DOI: 10.3389/fphar.2021.786182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
van Rheenen PF. Managing abnormal liver tests in children with inflammatory bowel disease. Curr Opin Pediatr 2021;33:521-9. [PMID: 34261897 DOI: 10.1097/MOP.0000000000001045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Teschke R, Danan G. The LiverTox Paradox-Gaps between Promised Data and Reality Check. Diagnostics (Basel) 2021;11:1754. [PMID: 34679453 DOI: 10.3390/diagnostics11101754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Watanabe M, Shibuya A, Yokomori H, Koizumi W. The Diagnosis of Drug-induced Liver Injury: Current Diagnostic Ability and Future Challenges of the Digestive Disease Week-Japan 2004 Scale 15 Years after Its Proposal. Intern Med 2021;60:2557-68. [PMID: 33716281 DOI: 10.2169/internalmedicine.6370-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 28 |
Kamath P, Kamath A, Ullal SD. Liver injury associated with drug intake during pregnancy. World J Hepatol 2021;13:747-62. [PMID: 34367496 DOI: 10.4254/wjh.v13.i7.747] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 29 |
Ho CM, Chen CL, Chang CH, Lee MR, Wang JY, Hu RH, Lee PH. Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment. Biomedicines 2021;9:891. [PMID: 34440095 DOI: 10.3390/biomedicines9080891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 31 |
He Y, Zhang W, Ma J, Xia Q, Song Z, Zhu L, Zhang C, Liu J, Ye Y, Fu PP, Zhuge Y, Lin G. Blood Pyrrole–DNA Adducts Define the Early Tumorigenic Risk in Patients with Pyrrolizidine Alkaloid-Induced Liver Injury. Environ Sci Technol Lett 2021;8:551-7. [DOI: 10.1021/acs.estlett.1c00359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 32 |
Vall A, Sabnis Y, Shi J, Class R, Hochreiter S, Klambauer G. The Promise of AI for DILI Prediction. Front Artif Intell 2021;4:638410. [PMID: 33937745 DOI: 10.3389/frai.2021.638410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 33 |
Xia C, Liu Y, Yao H, Zhu W, Ding J, Jin J. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature. J Int Med Res 2020;48:300060520917569. [PMID: 32293220 DOI: 10.1177/0300060520917569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 34 |
Teschke R, Danan G. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies. Int J Mol Sci 2021;22:3441. [PMID: 33810530 DOI: 10.3390/ijms22073441] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 35 |
Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 36 |
Pedraza L, Laosa O, Rodríguez-Mañas L, Gutiérrez-Romero DF, Frías J, Carnicero JA, Ramírez E. Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method. Front Pharmacol 2020;11:600255. [PMID: 33613279 DOI: 10.3389/fphar.2020.600255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 37 |
Malnick SDH, Abdullah A, Neuman MG. Checkpoint Inhibitors and Hepatotoxicity. Biomedicines 2021;9:101. [PMID: 33494227 DOI: 10.3390/biomedicines9020101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 38 |
González-Muñoz M, Monserrat Villatoro J, Marín-Serrano E, Stewart S, Bardón Rivera B, Marín J, Martínez de Soto L, Seco Meseguer E, Ramírez E. A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing. Clin Case Rep 2020;8:3105-9. [PMID: 33363890 DOI: 10.1002/ccr3.3348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 39 |
Kesenogile B, Godman B, Rwegerera GM. Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana. Expert Rev Anti Infect Ther 2021;19:379-91. [PMID: 32909487 DOI: 10.1080/14787210.2020.1822735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 40 |
Zheng W, Jiang F, Shan J, Wang Y, Jia Y, Guo Q, Lou J, Zhao Y. Levels of serum IgG subclasses in patients with liver disease: A retrospective study. Exp Ther Med 2021;21:45. [PMID: 33273974 DOI: 10.3892/etm.2020.9476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Shamseddeen H, Vilar-Gomez E, Chalasani N, Myers RP, Subramanian GM, Shlevin HH, Allgood AE, Orman ES. Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring. Drug Saf 2020;43:281-90. [PMID: 31907854 DOI: 10.1007/s40264-019-00896-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 42 |
Singh AK, Verma S, Kumar-M P, Soni H, Sharma S, Patil A, Sharma V. Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis.Expert Rev Clin Pharmacol. 2020;13:1253-1262. [PMID: 33043729 DOI: 10.1080/17512433.2020.1835468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 43 |
Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 44 |
Nunes V, Mendez-Sanchez N. Impact of Herbal and Dietary Supplements Causing Drug-Induced Liver Injury in Latin America. Clin Liver Dis (Hoboken) 2020;16:83-6. [PMID: 33005386 DOI: 10.1002/cld.905] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 45 |
Quan NV, Dang Xuan T, Teschke R. Potential Hepatotoxins Found in Herbal Medicinal Products: A Systematic Review. Int J Mol Sci 2020;21:E5011. [PMID: 32708570 DOI: 10.3390/ijms21145011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 46 |
Holtmann G, Schrenk D, Madisch A, Allescher HD, Ulrich-Merzenich G, Mearin F, Larrey D, Malfertheiner P. Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches. Dig Dis 2020;38:269-79. [PMID: 31770769 DOI: 10.1159/000504570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 47 |
Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 48 |
Mendes D, Oliveira AR, Alves C, Batel Marques F. Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysis. Expert Opin Drug Saf 2020;19:763-9. [PMID: 32167395 DOI: 10.1080/14740338.2020.1743262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 49 |
Teschke R. Acetaminophen syn. Paracetamol: Acute Liver Injury and Acute on Chronic Liver Failure with Case Analysis and Causality Assessment Using RUCAM. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_12] [Reference Citation Analysis]
|
| 50 |
Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 51 |
Volynets GV. FAMILIAL INTRAHEPATIC CHOLESTASIS IN CHILDREN: PROBLEMS AND PROSPECTS. RPJ 2019;22:388-394. [DOI: 10.18821/1560-9561-2019-22-6-388-394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 52 |
Zhu J, Chen M, Borlak J, Tong W. The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitis.Arch Toxicol. 2020;94:273-293. [PMID: 31720699 DOI: 10.1007/s00204-019-02621-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 53 |
Teschke R. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Front Pharmacol 2019;10:730. [PMID: 31396080 DOI: 10.3389/fphar.2019.00730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
|
